Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2006;47:288-295
Published online before print December 27, 2005, doi: 10.1161/01.HYP.0000198427.96225.36
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Correction (v47,pe23)
Right arrow All Versions of this Article:
47/2/288    most recent
01.HYP.0000198427.96225.36v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bek, M. J.
Right arrow Articles by Jose, P. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bek, M. J.
Right arrow Articles by Jose, P. A.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*High Blood Pressure
Hazardous Substances DB
*LOSARTAN POTASSIUM
*SODIUM

(Hypertension. 2006;47:288.)
© 2006 American Heart Association, Inc.


Original Articles

Angiotensin-II Type 1 Receptor–Mediated Hypertension in D4 Dopamine Receptor–Deficient Mice

Martin J. Bek; Xiaoyan Wang; Laureano D. Asico; John E. Jones; Shaopeng Zheng; XiaoXi Li; Gilbert M. Eisner; David K. Grandy; Robert M. Carey; Patricio Soares-da-Silva; Pedro A. Jose

From the Departments of Pediatrics (M.J.B., X.W., L.D.A., J.E.J., S.Z., X.L., P.A.J.) and Medicine (G.M.E.), Georgetown University Medical Center, Washington, DC; Department of Medicine (M.J.B.), University Clinics Muenster, Muenster, Germany; Department of Physiology and Pharmacology (D.K.G.), Oregon Health and Science University, Portland, Ore; University of Virginia Health Sciences Center (R.M.C.), Charlottesville, Va; and Institute of Pharmacology and Therapeutics (P.S-d-S.), Faculty of Medicine of Porto, Porto, Portugal.

Correspondence to Xiaoyan Wang, Dept of Pediatrics, Georgetown University Medical Center, 4000 Reservoir Rd, NW, Washington, DC 20057. E-mail xw22{at}georgetown.edu

Dopamine receptors are important in systemic blood pressure regulation. D4 receptors are expressed in the kidney and brain, but their role in cardiovascular regulation is unknown. In pentobarbital-anesthetized mice, systolic and diastolic blood pressures were elevated in sixth-generation D4 receptor–deficient (D4–/–) mice and in tenth-generation D4–/– mice compared with D4 wild-type (D4+/+) littermates. The conscious blood pressures measured via a chronic arterial (femoral) catheter or telemetry (carotid) were also higher in D4–/– mice than in D4 littermates. Basal renal and plasma renin concentrations were similar in the 2 mouse strains. The protein expression of angiotensin II type 1 receptor was increased in homogenates of kidney (330±53%, n=5) and brain (272±69%, n=5) of D4–/– mice relative to D4+/+ mice (kidney: 100±12%, n=5; brain: 100±32%, n=5). The expression of the receptor in renal membrane was also increased in D4–/– mice (289±28%, n=8) relative to D4+/+ mice (100±14%, n=10). In contrast, the expression in the heart was similar in the 2 strains. Bolus intravenous injection of angiotensin II type 1 receptor antagonist losartan initially decreased mean arterial pressures to a similar degree in D4–/– and D4+/+ littermates. However, the hypotensive effect of losartan dissipated after 10 minutes in D4+/+ mice, whereas the effect persisted for >45 minutes in D4–/– mice. We conclude that the absence of the D4 receptor increases blood pressure, possibly via increased angiotensin II type 1 receptor expression.


Key Words: dopamine • receptors, angiotensin II • mice • hypertension • angiotensin II • endothelin • vasopressins




This article has been cited by other articles:


Home page
Am. J. Physiol. Renal Physiol.Home page
H.-H. Hsu, K. Duning, H. H. Meyer, M. Stolting, T. Weide, S. Kreusser, T. van Le, C. Gerard, R. Telgmann, S.-M. Brand-Herrmann, et al.
Hypertension in mice lacking the CXCR3 chemokine receptor
Am J Physiol Renal Physiol, April 1, 2009; 296(4): F780 - F789.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Zeng, I. Armando, Y. Luo, G. M. Eisner, R. A. Felder, and P. A. Jose
Dysregulation of dopamine-dependent mechanisms as a determinant of hypertension: studies in dopamine receptor knockout mice
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H551 - H569.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. Armando, X. Wang, V. A. M. Villar, J. E. Jones, L. D. Asico, C. Escano, and P. A. Jose
Reactive Oxygen Species-Dependent Hypertension in Dopamine D2 Receptor-Deficient Mice
Hypertension, March 1, 2007; 49(3): 672 - 678.
[Abstract] [Full Text] [PDF]